Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65 years of age and older: A phase II, observer-blind, randomized, controlled trial.
Saved in:
| Title: | Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65 years of age and older: A phase II, observer-blind, randomized, controlled trial. |
|---|---|
| Authors: | Madan, Anuradha1 Anu.2.Madan@gsk.com, Ferguson, Murdo2, Rheault, Paul3, Seiden, David4, Toma, Azhar5 azhar.toma@mannaresearch.com, Friel, Damien6 damien.j.friel@gsk.com, Soni, Jyoti7, Li, Ping1 ping.li4@pfizer.com, Innis, Bruce L.1 bruce.2.innis@gsk.com, Schuind, Anne1 |
| Source: | Vaccine. Apr2017, Vol. 35 Issue 15, p1865-1872. 8p. |
| Database: | Environment Complete |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: eih DbLabel: Environment Complete An: 122037171 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65 years of age and older: A phase II, observer-blind, randomized, controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Madan%2C+Anuradha%22">Madan, Anuradha</searchLink><relatesTo>1</relatesTo><i> Anu.2.Madan@gsk.com</i><br /><searchLink fieldCode="AR" term="%22Ferguson%2C+Murdo%22">Ferguson, Murdo</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Rheault%2C+Paul%22">Rheault, Paul</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Seiden%2C+David%22">Seiden, David</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Toma%2C+Azhar%22">Toma, Azhar</searchLink><relatesTo>5</relatesTo><i> azhar.toma@mannaresearch.com</i><br /><searchLink fieldCode="AR" term="%22Friel%2C+Damien%22">Friel, Damien</searchLink><relatesTo>6</relatesTo><i> damien.j.friel@gsk.com</i><br /><searchLink fieldCode="AR" term="%22Soni%2C+Jyoti%22">Soni, Jyoti</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Li%2C+Ping%22">Li, Ping</searchLink><relatesTo>1</relatesTo><i> ping.li4@pfizer.com</i><br /><searchLink fieldCode="AR" term="%22Innis%2C+Bruce+L%2E%22">Innis, Bruce L.</searchLink><relatesTo>1</relatesTo><i> bruce.2.innis@gsk.com</i><br /><searchLink fieldCode="AR" term="%22Schuind%2C+Anne%22">Schuind, Anne</searchLink><relatesTo>1</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Vaccine%22">Vaccine</searchLink>. Apr2017, Vol. 35 Issue 15, p1865-1872. 8p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=eih&AN=122037171 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2017.02.057 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 1865 Titles: – TitleFull: Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65 years of age and older: A phase II, observer-blind, randomized, controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Madan, Anuradha – PersonEntity: Name: NameFull: Ferguson, Murdo – PersonEntity: Name: NameFull: Rheault, Paul – PersonEntity: Name: NameFull: Seiden, David – PersonEntity: Name: NameFull: Toma, Azhar – PersonEntity: Name: NameFull: Friel, Damien – PersonEntity: Name: NameFull: Soni, Jyoti – PersonEntity: Name: NameFull: Li, Ping – PersonEntity: Name: NameFull: Innis, Bruce L. – PersonEntity: Name: NameFull: Schuind, Anne IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 04 Text: Apr2017 Type: published Y: 2017 Identifiers: – Type: issn-print Value: 0264410X Numbering: – Type: volume Value: 35 – Type: issue Value: 15 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |
